FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea
Source:
Nasdaq GlobeNewswire
/
26 Feb 2024 16:05:00 America/New_York
N/A
Share on,